CD30 Expression by B and T Cells-Reference-Cited by-同舟云学术

CD30 Expression by B and T Cells

Published:2016-03 Issue:3 Volume:40 Page:378-385
ISSN:0147-5185
Container-title:American Journal of Surgical Pathology
language:en
Short-container-title:

Author:

Onaindia Arantza,Martínez Nerea,Montes-Moreno Santiago,Almaraz Carmen,Rodríguez-Pinilla Socorro M.,Cereceda Laura,Revert Jose B.,Ortega César,Tardio Antoni,González Lucía,García Sonia,Camacho Francisca I.,González-Vela Carmen,Piris Miguel A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pathology and Forensic Medicine,Surgery,Anatomy

Reference17 articles.

1. . Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors.;Mak;J Clin Oncol,2013

2. . Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study.;OConnor;J Clin Oncol,2011

3. . Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy.;Coiffier;J Clin Oncol,2012

4. . Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study.;Pro;J Clin Oncol,2012

5. . Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkins disease.;Durkop;Cell,1992

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic analysis reveals molecular characterization of CD30+ and CD30− extranodal natural killer/T-cell lymphomas (ENKTLs);Human Pathology;2024-10

2. Optimizing assessment of CD30 expression in Hodgkin lymphoma by controlling for low expression;HISTOL HISTOPATHOL;2024

3. Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions;Haematologica;2023-11-21

4. Brentuximab vedotin in treating Chinese patients with lymphoma: A multicenter, real‐world study;Cancer Medicine;2023-11-17

5. CD30 in Cutaneous Pathology;The American Journal of Dermatopathology;2023-09